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AbstrAct
Objectives Incisional hernias are common complications 
of midline abdominal closure. The ‘Hughes Repair’ 
combines a standard mass closure with a series of 
horizontal and two vertical mattress sutures within a single 
suture. There is evidence to suggest this technique is as 
effective as mesh repair for the operative management 
of incisional hernias; however, no trials have compared 
Hughes repair with standard mass closure for the 
prevention of incisional hernia formation. This paper aims 
to test the feasibility of running a randomised controlled 
trial of a comparison of abdominal wall closure methods 
following midline incisional surgery for colorectal cancer, 
in preparation to a definitive randomised controlled trial.
Design and setting A feasibility trial (with 1:1 
randomisation) conducted perioperatively during colorectal 
cancer surgery.
Participants Patients undergoing midline incisional 
surgery for resection of colorectal cancer.
Interventions Comparison of two suture techniques 
(Hughes repair or standard mass closure) for the closure 
of the midline abdominal wound following surgery for 
colorectal cancer.
Primary and secondary outcomes A 30-patient 
feasibility trial assessed recruitment, randomisation, 
deliverability and early safety of the surgical techniques 
used.
results A total of 30 patients were randomised from 
43 patients recruited and consented, over a 5-month 
period. 14 and 16 patients were randomised to arms A 
and B, respectively. There was one superficial surgical 
site infection (SSI) and two organ space SSIs reported 
in arm A, and two superficial SSIs and one complete 
wound dehiscence in arm B. There were no suspected 
unexpected serious adverse reactions reported in either 
arm. Independent data monitoring committee found no 
early safety concerns.
conclusions The feasibility trial found no early safety 
concerns and demonstrated that the trial was acceptable 
to patients. Progression to the pilot and main phases of 
the trial has now commenced following approval by the 
independent data monitoring committee.
trial registration number ISRCTN 25616490.
IntrODuctIOn
Incisional hernias are common compli-
cations of midline abdominal incisions, 
with a reported incidence of 12.8% at 2 
years of follow-up in a systematic review of 
14 618 patients.1 Within patients who have 
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Research
strengths and limitations of this study
 ► This feasibility trial is not powered for a definitive 
study and simply reports the recruitment, 
deliverability and safety.
 ► We report blinded outcome data and have not 
included incisional hernia rates in order to prevent 
the introduction of bias or reduction of equipoise for 
future recruitment of the main trial.
 ► We acknowledge that randomising immediately 
prior to abdominal closure may increase the risk of 
selection bias into the trial; however, to overcome 
this we have collected information on the reasons 
why patients were not randomised after consenting 
in the screening log.
 ► The setting of the feasibility trial was chosen as the 
trial’s lead site: a high-volume teaching hospital. 
This poses a potential limitation for the main trial at 
lower volume centres, in terms of ability to recruit 
participants over the time period (3 years).
 ► The Hughes Abdominal Repair Trial is a pragmatic 
trial, and as such we are allowing the control (mass 
closure) arm to be the responsible consultant 
surgeon’s standard closure technique, and 
acknowledge that this may introduce a degree of 
variability in the control arm.
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Figure 1 Diagram showing the Hughes closure method, 
using a combination of standard mass closure with a series 
of horizontal and two vertical mattress sutures within a single 
suture. When the sutures are pulled to close the defect, the 
sutures lie both across and along the incision.
undergone colorectal cancer resectional surgery, the rate 
of incisional hernia has been reported as high as 39.9%, 
including both open and laparoscopic approaches (40.9% 
and 37.1%, respectively).2 They can result in significant 
morbidity and impaired quality of life,3 and frequently 
require emergency surgery. Despite recent develop-
ment in mesh technology, incisional hernia repair still 
has disappointingly high recurrence rates (up to 54% in 
suture repair and up to 36% in mesh repair).4 5 Preven-
tion of the development of incisional hernia therefore 
brings significant benefits for both patients and health-
care provision funding.
‘Mass closure’ remains the standard technique for 
abdominal closure (closing all layers of the abdominal 
wall, excluding the skin), with either non-absorbable or 
slow-resorbing sutures, such as polydioxanone (PDS).6 
A systematic review and meta-regression of over 14 000 
patients found no difference in incisional hernia rate 
comparing suture material.1 This poses the question as 
to whether improved suture technique may reduce inci-
sional hernia formation. The STITCH trial,7 a Dutch 
multicentre, randomised controlled trial, compared 
small-stitch continuous sutures with large-stitch standard 
mass closure in 560 patients. Results demonstrated a 
reduction in the rate of incisional hernia from 21% in 
the large bite group to 13% in the small bite group at 
1-year follow-up. The CONTINT trial, currently still in 
recruitment, is comparing continuous with interrupted 
sutures in closing midline incisions after emergency 
laparotomy.8
The European Hernia Society Guidance on the closure 
of abdominal wall incisions (2015) recommended the 
use of prophylactic mesh augmentation for an elective 
midline laparotomy in a high-risk patient in order to 
reduce the risk of incisional hernia.9 However, first, they 
determined that the evidence base for this was weak, and 
second in the UK mesh augmentation closure is infre-
quently used. It is for these reasons that it is still critical 
for other closure methods to be rigorously assessed for 
their role in incisional hernia prevention.
The eponymously titled ‘Hughes Repair’ (Professor Les 
Hughes, 1932–2011),10 also known as the ‘far-and-near’ 
or ‘Cardiff Repair’,11 combines a standard mass closure 
(two-loop 1 PDS sutures) with a series of horizontal and 
two vertical mattress sutures within a single suture (1 
nylon), theoretically distributing the load along the inci-
sion length as well as across it (figure 1). The following 
are the principles:
1. To ensure, by palpation, that only sound normal tis-
sues are used for the repair.
2. To use graduated tension for easy approximation.
3. Use a monofilament nylon suture, which has the ad-
vantage of slipping easily through tissues to create a 
pulley system.12
The Hughes repair has been shown to have outcomes 
as effective as the standard mesh repair in incisional 
hernia repairs.13 It is also used for closing abdomens 
when patients are at high risk of incisional hernias, 
after complete abdominal wound dehiscence and 
laparostomy.14
This feasibility trial aimed to establish whether a 
randomised controlled trial to compare Hughes repair 
with standard mass closure for prevention of midline inci-
sional hernia, in patients undergoing colorectal cancer 
resectional surgery, would be deemed acceptable to 
patients, achieve adequate recruitment and result in no 
early safety concerns.
MethODs/DesIgn
study design
The Hughes Abdominal Repair Trial (HART) hypothesis 
is that the Hughes repair will reduce the incidence of 
clinically detected incisional hernia at 1 year in patients 
undergoing midline abdominal wall closure incisions 
following elective or emergency colorectal cancer surgery 
when compared with standard mass closure (figure 2). 
This is a 1:1 randomised controlled trial comparing two 
suture techniques for the closure of the midline abdom-
inal wound following surgery for colorectal cancer.
setting and location
The feasibility trial took place at the trial’s lead site Univer-
sity Hospital of Wales, Cardiff, a high-volume teaching 
hospital (1 of the 20 proposed recruitment sites for the 
main trial).
Aims and outcome measures
The feasibility trial aimed to assess the ability of the trial 
to recruit and consent patients over a 5-month period 
and the deliverability and safety of the Hughes repair. 
The acceptability was assessed in terms of percentage 
of consenting versus refusing participants. Adequacy 
of recruitment is assessed in terms of number of 
recruited participants. Operation-specific adverse events 
(AEs) collected included surgical site infection and full 
wound dehiscence. Early surgical safety was assessed in 
terms of serious event and wound complication rates. In 
this paper we report blinded outcome data and have not 
included incisional hernia rates in order to prevent the 
introduction of bias or reduction of equipoise for future 
recruitment of the main trial.
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Figure 2 Hughes Abdominal Repair Trial study design.
Independent data monitoring committee reviewed the 
unblinded safety data after completion of the feasibility 
phase. The outcome measures for the full trial have been 
previously reported,15 with the primary outcome measure 
being the rate of incisional hernia at 1-year follow-up 
assessed by clinical examination. The full trial protocol 
can be accessed via the following link: https:// njl- admin. 
nihr. ac. uk/ document/ download/ 2007245. Follow-up 
will continue for 5 years postoperatively; however, in 
this paper, only 12-month lost to follow-up data will be 
presented as the aim of this feasibility trial is to assess the 
deliverability and safety of the trial.
eligibility criteria
Eligibility criteria were assessed at two time points: at initial 
screening and at point of surgical closure/randomisation. 
Adult patients (aged 18 year or over), able to give informed 
consent, and undergoing either elective colorectal cancer 
surgery following full staging investigations including an 
abdominal CT scan or emergency surgery in those with a 
strong suspicion of colorectal cancer on abdominal CT 
scan were eligible at point of initial screening. All patients 
had to be suitable for either Hughes repair or standard 
mass closure. At point of surgical closure, eligibility was 
further assessed, and all patients who had a midline inci-
sion (open or laparoscopic assisted/converted) of 5 cm or 
more in length were deemed suitable for randomisation. 
Patients requiring mesh insertion or having an abdom-
inal musculofascial flap for closure of the perineal defect 
in abdominoperineal wound closure were excluded.
consent
Patients were identified, approached and provided with 
a patient information leaflet. Consent for trial participa-
tion was gained by either consultant surgeons or surgical 
registrars who had current ‘Good Clinical Practice’ 
certification.
randomisation and data collection
An adaptive randomisation design was used to allocate 
eligible patients to groups of similar size. This rando-
misation is based on an independent, computer-based 
sequence, generated from an implementation of the 
dynamic algorithm, using operation category (elective 
or emergency) and surgeon as stratifying variables.16 
Patients were randomised in a 1:1 ratio to either mass 
closure or Hughes repair. Randomisation took place 
during surgery and as close as possible to the time when 
the surgeon commenced closure. During the feasibility 
trial, a telephone randomisation system was used. The 
patient was blinded to the treatment allocation assigned 
to them. Data management was supported by the Swansea 
Trials Unit.
surgical quality assurance
To assure the quality of the repair techniques, all surgeons 
participating in the trial (consultants and registrars) 
completed training and quality assessment on the Hughes 
repair. All participating surgeons were assessed by the 
chief investigator and were approved only when closure 
technique was satisfactory. A reference instructional video 
was provided to participating surgeons. To monitor the 
training of professionals contributing to HART, a log was 
maintained with the details of training, both surgical and 
in research governance notably ‘Good Clinical Practice’. 
For the purposes of this pragmatic study, mass closure was 
taken to be the responsible consultant surgeon’s standard 
closure technique.
radiological evaluation of incisional hernia
A dedicated trial radiologist determined whether there 
was a hernia present on the 1-year colorectal cancer 
surveillance CT scan. They defined an incisional hernia 
as herniation of the bowel or other intra-abdominal 
content outside the abdominal wall, and also identified 
the presence of other hernias and the quality of the recti 
muscle. All scans were performed using the standard 
departmental protocol for follow-up scans.
sample size
The feasibility trial aimed to recruit a total of 30 patients 
over a 5-month period, because the HART trial manage-
ment group felt that such a sample size was indicative of 
the ability to recruit the sample proposed for the main 
trial within the established time frame. The sample size 
for the main study has been published previously.14
Adverse events
An AE was defined as any untoward medical occurrence 
in a clinical trial participant to whom a study interven-
tion has been administered and which does not neces-
sarily have a causal relationship with this treatment. 
An AE can therefore be any unfavourable and unin-
tended sign (including abnormal laboratory finding), 
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Figure 3 Consolidated Standards of Reporting Trials diagram.
symptom or disease. The following are the AEs that are 
considered expected for patients undergoing colorectal 
surgery: lower respiratory tract infection, urinary tract 
infection, anastomotic leak, intra-abdominal sepsis, 
deep vein thrombosis, pulmonary embolus, wound 
infection, surgical site infection, wound breakdown, 
paralytic ileus, bleeding, myocardial infarction and 
stoma complications (prolapsed, retraction, dehiscence 
or hernia). However, if these events lead to death, that 
would be considered unexpected. These events may be 
classified as serious and will be recorded as such but will 
not require reporting to Research Ethics Committee. 
Additional information may be requested for AEs of 
special interest such as wound breakdown and surgical 
site infections.
A serious adverse event (SAE) is an adverse event that 
results in any of the following: death, was life-threatening, 
required hospitalisation or prolongation of existing 
hospitalisation, persistent or significant disability or inca-
pacity, consists of a congenital anomaly or birth defect, 
or is otherwise considered medically significant by the 
investigator.
statistical analysis
A two-tailed Fisher’s exact test was used to compare SAE 
rate between both arms. Differences were considered to 
be statistically significant at P≤0.05.
results
recruitment and randomisation
A total of 62 patients were screened and assessed for eligi-
bility for entry into the trial over a 5-month time period, 
October 2013 to February 2014 (figure 3). Of those 
screened, 43 patients consented to entry into the trial 
(69%). A total of 30 of the 43 patients were randomised 
in the operating theatre (14 patients were randomised to 
arm A and 16 patients were randomised to arm B). The 
reasons for exclusion are described in the Consolidated 
Standards of Reporting Trials diagram (figure 3).
For the 30 patients who were randomised, the median 
age was 74 years (IQR 66–78). There were 23 men and 
7 women. Demographical data are presented in table 1.
In arm A, one patient had died prior to 12-month 
follow-up and a further patient had transferred care to 
another unit. In arm B, one patient had died prior to 
12-month follow-up.
safety data
There were a total of 16 SAEs reported in 10 patients 
(table 2); SAE rate was 34% in arm A and 31% in arm B 
(P=1.0000). There were no suspected unexpected serious 
adverse reactions reported in either arm. With regard to 
wound-related complications, there was one superficial 
surgical site infection and two organ space surgical site 
infections reported in arm A, and two superficial surgical 
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Table 1 Patient demographics and clinical characteristics
Arm A
(n=14)
Arm B
(n=16)
Total
(n=30)
Gender, n (%)
  Male 10 (71) 13 (81) 23 (77)
  Female 4 (29) 3 (19) 7 (23)
Median age (IQR) 75 (61–78) 73 (68–77) 74 (66–78)
Mean BMI (Min–max) 30 (22–49) 29 (18–42) 29 (18–49)
Smoker, n (%) 1 (7) 3 (19) 4 (13)
Steroid/immuno
suppression use, n (%)
0 (0) 0 (0) 0 (0)
Diabetes, n (%) 5 (36) 4 (25) 9 (30)
Connective tissue 
disorder, n (%)
1 (7) 0 (0) 1 (3)
COPD, n (%) 1 (7) 2 (13) 3 (10)
AAA (known or 
previous repair), n (%)
0 (0) 0 (0) 0 (0)
Previous abdominal 
surgery, n (%)
8 (57) 8 (50) 15 (50)
Neoadjuvant 
chemotherapy, n (%)
1 (7) 0 (0) 1 (3)
Neoadjuvant 
radiotherapy, n (%)
1 (7) 1 (6) 2 (7)
Incisional hernia 
present preoperatively, 
n (%)
0 (0) 1 (6) 1 (3)
Previous incisional 
hernia repair, n (%)
1 (7) 0 (0) 1 (3)
Non-incisional hernia 
present preoperatively, 
n (%)
0 (0) 3 (19) 3 (10)
Mode of surgery, n (%)
  Laparoscopic 4 (27) 6 (38) 10 (33)
  Laparoscopic 
converted
7 (50) 3 (19) 10 (33)
  Open 3 (21) 7 (44) 10 (33)
AAA, abdominal aortic aneurysm; BMI, body mass index; 
COPD, chronic obstructive pulmonary disease.
Table 2 Reported serious adverse events (SAEs)
Arm A Arm B
Myocardial infarction 2 2
Lower respiratory tract infection 2 1
Pulmonary embolism 1 0
Renal failure 0 1
Anastomotic leak 2 0
Parastomal hernia 0 1
Superficial surgical site infection 2 0
Dehiscence 0 1
Death* 1 0
Total SAEs 10 6
Total patients affected 5 5
*1 SAE reported was reported as ‘death’; therefore, it had to 
be listed as an event of death. There were two other SAEs that 
resulted in death within the feasibility study.
Table 3 Wound-related complications
Arm A Arm B
Superficial SSI 1 2
Deep SSI 0 0
Organ space SSI 2 0
Wound dehiscence 0 1
Total wound-related complications 3 3
The data monitoring committee reviewed the unblinded adverse 
events data and identified no safety concerns.
SSI, surgical site infection.
site infections and one complete wound dehiscence 
requiring a return to theatre in arm B (table 3).
DIscussIOn
The results of this feasibility trial demonstrated that a 
randomised controlled trial designed to compare two 
suture techniques for the prevention of midline inci-
sional hernia, in patients undergoing cancer resectional 
surgery, was able to recruit 30 patients over 5 months, as 
planned. This suggests that the proposed sample size of 
800 patients for the main full trial is achievable in the 
time scale with the proposed number of sites recruiting 
(approximately 20).14
The feasibility trial results established that the trial 
was acceptable to patients. Patient participation rates 
were high, demonstrated by 69% of all eligible patients 
consenting to participation in the trial. Nine patients 
were screened for eligibility but not consented due to 
staff shortages, highlighting the importance of having 
adequate number of approved consenting staff on the 
delegation log. Due to the nature of the study, it was 
accepted that not all patients consented would even-
tually be randomised. In fact, there was a higher than 
expected number of patients consented and not eventu-
ally randomised (31%). Patients were consented but not 
randomised if the intraoperative procedure performed 
did not meet the inclusion criteria, for example not 
midline incision, conversion to open procedure using a 
non-midline incision or emergency patients found not to 
have a tumour intraoperatively. We acknowledge that this 
method may increase the risk of selection bias into the 
trial; however, to overcome this, we have collected infor-
mation on the reasons why patients were not randomised 
after consenting (figure 3).
The setting of the feasibility trial was chosen as the 
trial’s lead site, a high-volume teaching hospital. This 
poses a potential limitation for the main trial at lower 
volume centres, in terms of ability to recruit participants 
over the time period (3 years). However, the sample size 
required for the pilot and main trial is 800 across roughly 
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20 sites, which equates to 40 participants required per site 
and should be achievable over the trial time period, even 
for lower volume centres, particularly given the incidence 
of colorectal cancer within the UK.
The HART trial is a pragmatic trial, and as such we are 
allowing the control (mass closure) arm to be the respon-
sible consultant surgeon’s standard closure technique. 
We acknowledge that this may introduce a degree of vari-
ability in the control arm, but in order to counter this our 
sample size for the main trial has been powered to be able 
to stratify for site and surgeon.
The SAE rate and wound-related complications were 
similar between both arms, and reassuringly there were 
no suspected unexpected serious adverse reactions 
reported. It is anticipated that reporting on the full trial 
will take place in 2019.
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